Cramer looks at multiple sclerosis in the final installment of this weeklong series.
What stays and what goes? Let Cramer help you decide.
Here's our "Fast Money" Final Trade, where the traders share their best plays for Friday.
Stocks ended higher amid light volume for a second straight day Thursday following a pair of upbeat economic reports. Adobe jumped, McDonald's slipped.
Stocks rose modestly in light late-afternoon trading Thursday after a pair of upbeat economic reports. Adobe jumped, McDonald's slipped.
Stocks rose Thursday after encouraging readings on jobless claims and the trade deficit. Financials led the way, while McDonald's capped gains on the Dow.
Here's why you should keep a close eye on these six stocks.
Here’s his diversified portfolio of the top stock players right now.
Here’s our Fast Money Final Trade, where the 'Fast' traders give you the best plays for Thursday.
Here's our Fast Money Final Trade. Our gang gives you Monday's best trades, right now!
Cramer makes the call on viewers' favorite stocks.
What follows is a roundup of corporate earnings reports for Tuesday, July 27.
Earnings news Tuesday may again be the catalyst for a stock market that's showing improving technical strength.
Here's our Fast Money Final Trade. Our gang gives you Tuesday's best trades, right now!
Stocks fell sharply Tuesday as doubts about China's growth and a disappointing U.S. consumer-confidence reading rattled an already jittery market.
Stocks opened sharply lower Tuesday amid a fresh round of worries about euro-zone debt as bank repayments come due to the European Central Bank this week.
Most bank stocks were higher on Friday after Congress reached a deal on financial reform. Nick Kalivas, vice president of financial research at MF Global and Jim Meyer, CIO and co-founder of Tower Bridge Advisors offered their insights—and 14 favorite stocks.
European companies that export their goods are sure bets for investing, two fund managers told CNBC Thursday.
In today's world, the process of providing access to affordable healthcare should be easier than it is. Globally, we're all affected by the rising costs of healthcare in the face of an aging population – increasing expenditures for healthcare is a challenge in every country where Teva has a presence.
The Mad Money host takes your questions.